AFP Acute Flaccid Paralysis bOPV bivalent OPV (contains Sabin types 1 and 3) CAG Containment Advisory Group CCO Cold Chain Officer cVDPV Circulating Vaccine-derived Poliovirus DVAMS District Vaccine Accountability Monitoring Supervisor EOC Emergency Operations Centre EUL WHO Emergency Use Listing Procedure EPI Expanded Programme on Immunization GPEI Global Polio Eradication Initiative IM Independent Monitoring IPV Inactivated Polio Vaccine LWG Logistics Working Group mOPV2 Sabin Monovalent OPV (containing type 2) nOPV2 Novel OPV type 2 NAC National Authority for Containment NCC National Certification Commission for the Eradication of Poliomyelitis NPCC National Poliovirus Containment Coordinator NGO Non-Governmental Organization NLWG National Logistics Working Group NPCC National Poliovirus Containment Coordinator NRA National Regulatory Authority OBRA Outbreak and Response Assessment OPRTT Outbreak Preparedness and Response Task Team OPV Oral Polio Vaccine PHEIC Public Health Emergency of International Concern RI Routine Immunization RR Rapid Response RCC Regional Certification Commission SAGE Strategic Advisory Group of Experts on Immunization SIA Supplementary Immunization Activities SOPs Standard Operating Procedures SR Surge Response STOP Stop Transmission of Polio tOPV Trivalent OPV (contains Sabin类型1、2和3)联合国儿童基金会联合国儿童基金VAM疫苗问责制监视器VDPV疫苗衍生的poliovirus VVM疫苗疫苗VIAL VIAL MONITY谁世界卫生组织WPV野生poliovirus
60923-501-10:10个小瓶(100毫升总剂量)60923-502-11:11小瓶(110ml总剂量体积)60923-503-12:12个小瓶(120ml剂量量 dose volume) 60923-506-15: 15 vials (150mL total dose volume) 60923-507-16: 16 vials (160mL total dose volume) 60923-508-17: 17 vials (170mL total dose volume) 60923-509-18: 18 vials (180mL total dose volume) 60923-510-1: 19 vials (190mL总剂量体积)60923-511-20:20个小瓶(200ml总剂量体积)60923-512-21:21个小瓶(210ml总剂量体积)60923-513-22:22小瓶(220ml剂量体积(240毫升总剂量体积)60923-516-25:25个小瓶(250毫升总剂量体积)60923-517-26:26个小瓶(260ml总剂量体积)60923-518-27:27小瓶(270ml总剂量(270ml总剂量) 60923-520-29:29个小瓶(290毫升总剂量体积)60923-521-30:30小瓶(300ml总剂量体积)60923-522-31:31个小瓶(310ml剂量总量小瓶(330毫升总剂量体积)60923-525-34:34小瓶(340ml总剂量体积)60923-526-35:35瓶(350ml总剂量体积)60923-527-36:36小瓶(360ml总数剂量体积)60923-529-38:38个小瓶(380ml总剂量体积)60923-530-39:39瓶(390ml总剂量体积)60923-531-40:40小瓶(400ml剂量体积)
• The 133 mg (10 mL) and 266 mg (20 mL) doses of EXPAREL are available in cartons of 4 and 10 vials • EXPAREL vials should be stored and refrigerated between 2°C to 8°C (36°F to 46°F) • Sealed, intact (unopened) EXPAREL vials may be held at a controlled room temperature of 20°C to 25°C (68°F至77°F)最多30天。小瓶不应重新填充•不应冷冻膨胀•长期不应长时间暴露于高温(> 40°C或104°F)•长期内•如果不怀疑被冻结或暴露于高温下,则不应在视觉上进行视觉检查。如果塞子凸起,请勿使用小瓶•应在4小时内使用exparel的开放小瓶•exparel的小瓶多次将小瓶重悬于从小瓶中撤回之前的颗粒,然后再恢复颗粒。
▪ Update contact information under Edit Organization prior to completing return ▪ Return single dose syringes, unopened single dose vials, and only full, unopened multi-dose vials ▪ Print nonviable vaccine return list from the Manage Returns page using the blue hyperlink and include the return list in the box ▪ Print the UPS postage paid return label emailed from McKesson
BAX ® System Free DNA Cleanup Kit Part KIT2041 KIT CONTENTS - (96 TESTS) 2 vials of Free DNA Cleanup Agent (290 μL each) 2 vials of Free DNA Cleanup Buffer (290 μL each) 2 vials of Inactivation Agent (290 μL each) INTENDED USE The BAX ® System Free DNA Cleanup Kit can be used to remove DNA not protected通过食物和环境矩阵的活细胞。这种易于使用的套件可去除所有外部DNA,包括来自死细胞的DNA和噬菌体干预的DNA残留物,设计用于与Bax®System方法易于整合。使用场:从Bax®系统获得的数据不应用于人类诊断或人类治疗目的。设备未经美国食品药品监督管理局或任何其他美国或非美国的监管机构批准用于人类诊断或治疗。Bax®系统不应用作评估产品发布给消费者的安全性的唯一基础。生成的信息仅与用户的常规质量保证计划一起使用。未批准用于临床诊断。在技术合格人员的监督下,用于研发,质量保证和质量控制。
Manufacturer: Perkin Elmer Model: Tri-Carb LSC 4810TR110 V Sample Vial Capability: 336 Standard vials 648 Miniature vials Calculation types: Counts per minute (CPM) Disintegrations per minute (DPM) Scintillation Efficiencies: Isotope LSC efficiency C-14 96 % H-3 65 % P-32 & P-33 100 % S-35 97 % Cr-51 35 % Cs-137 100 % I-125 78 % Small check source: Cs-137 @ 30 u ci (microcuries) Printer: Brothers CRT: Color, Black and Off White Reference samples: Background Standard (BKG) H3 standard and C14 standard Product Dimensions: Width: 103 cm Height: 47 cm Depth: 81 cm Weight: 480 lbs Minimum Power Requirements: 120 V 3.0 240 V 1.5 A
药物优势和可用的小瓶SIOP-LGG-2004感应卡铂强度10mg/ml; 5、15、45和60毫升长春新碱强度为1mg/ml的小瓶;在过敏或早期进展的情况下,1和2ML巩固卡铂的固结
包装规格: 纸盒内含 1 个玻璃或塑料小瓶(5 剂)。 纸盒内含 1 个玻璃或塑料小瓶(10 剂) 纸盒内含 1 个玻璃或塑料小瓶(25 剂) 纸盒内含 1 个玻璃或塑料小瓶(50 剂) 纸盒内含 1 个玻璃或塑料小瓶(100 剂) 纸盒内含 10 个玻璃或塑料小瓶(5 剂) 纸盒内含 10 个玻璃或塑料小瓶(10 剂) 纸盒内含 10 个玻璃或塑料小瓶(25 剂) 纸盒内含 10 个玻璃或塑料小瓶(50 剂) 纸盒内含 10 个玻璃或塑料小瓶(100 剂)
疫苗必须在冷藏储存过程中直立存储。不应将它们倒置或侧面存储。Pfizer/BioNTech has no stability data for thawed vials stored on their side for a prolonged period and cannot support the use of these vials.如果一个小瓶在处理过程中短时间落在其一边,并且在短时间内就在其侧面,则应进行矫正并可以使用。如果小瓶落在地板上,则有发际线骨折的风险可能对肉眼看不到。因此,制造商建议不要使用它。不要摇动疫苗小瓶。